Danaher Net Total Equity Issued/Repurchased 2010-2025 | DHR
Danaher annual/quarterly net total equity issued/repurchased history and growth rate from 2010 to 2025. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
- Danaher net total equity issued/repurchased for the quarter ending March 31, 2025 was $-1.083B, a 108200% increase year-over-year.
- Danaher net total equity issued/repurchased for the twelve months ending March 31, 2025 was $-16.381B, a 14469.3% decline year-over-year.
- Danaher annual net total equity issued/repurchased for 2024 was $-5.817B, a 8654.41% decline from 2023.
- Danaher annual net total equity issued/repurchased for 2023 was $0.068B, a 119.35% increase from 2022.
- Danaher annual net total equity issued/repurchased for 2022 was $0.031B, a 63.95% decline from 2021.
| Danaher Annual Net Total Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $-5,817 |
| 2023 | $68 |
| 2022 | $31 |
| 2021 | $86 |
| 2020 | $3,550 |
| 2019 | $3,816 |
| 2018 | $96 |
| 2017 | $4 |
| 2016 | $165 |
| 2015 | $249 |
| 2014 | $133 |
| 2013 | $177 |
| 2012 | $-436 |
| 2011 | $1,113 |
| 2010 | $178 |
| 2009 | $174 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $142.454B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||